{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:16:23Z","timestamp":1789409783844,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NA"},{"name":"CIHR, Cystic Fibrosis Canada, Lung Association of Alberta and NWT"},{"name":"CIHR, Cystic Fibrosis Canada, Lung Association of Alberta and NWT, Crohn&apos;s and Colitis Foundation of Canada"},{"name":"NSERC, Lung Association of Alberta and NWT"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A diverse microbiota exists within the airways of individuals with non-cystic fibrosis bronchiectasis (nCFB). How the lung microbiome evolves over time, and whether changes within the microbiome correlate with future disease progression is not yet known. We assessed the microbial community structure of 133 serial sputa and subsequent disease course of 29 nCFB patients collected over a span of 4\u201316 years using 16S rRNA paired-end sequencing. Interestingly, no significant shifts in the microbial community of individuals were observed during extended follow-up suggesting the microbiome remains relatively stable over prolonged periods. Samples that were\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    culture positive displayed markedly different microbial community structures compared to those that were positive for\n                    <jats:italic>Haemophilus influenzae<\/jats:italic>\n                    . Importantly, patients with sputum of lower microbial community diversity were more likely to experience subsequent lung function decline as defined by annual change in \u2265\u22121 FEV\n                    <jats:sub>1<\/jats:sub>\n                    % predicted. Shannon diversity values &lt;1 were more prevalent in patients with FEV\n                    <jats:sub>1<\/jats:sub>\n                    decline (P\u2009=\u20090.002). However, the relative abundance of particular core microbiota constituents did not associate with risk of decline. Here we present data confirming that the microbiome of nCFB individuals is generally stable, and that microbiome-based measurements may have a prognostic role as biomarkers for nCFB.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-42862-y","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T06:04:46Z","timestamp":1556863486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome"],"prefix":"10.1038","volume":"9","author":[{"given":"T. E.","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Heirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7264-3679","authenticated-orcid":false,"given":"C. H.","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Surette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"42862_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","volume":"12","author":"D Weycker","year":"2005","unstructured":"Weycker, D., Edelsberg, J., Oster, G. & Tino, G. Prevalence and economic Burden of Bronchiectasis. Clin. Pulm. Med. 12, 205\u2013209 (2005).","journal-title":"Clin. Pulm. Med."},{"key":"42862_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1183\/09031936.06.00074605","volume":"28","author":"G Davies","year":"2006","unstructured":"Davies, G., Wells, A. U., Doffman, S., Watanabe, S. & Wilson, R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur. Respir. J. 28, 974\u20139 (2006).","journal-title":"Eur. Respir. J."},{"key":"42862_CR3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1378\/chest.114.6.1594","volume":"114","author":"PL Ho","year":"1998","unstructured":"Ho, P. L. et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 114, 1594\u20131598 (1998).","journal-title":"Chest"},{"key":"42862_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2180-14-130","volume":"14","author":"P Purcell","year":"2014","unstructured":"Purcell, P. et al. Polymicrobial airway bacterial communities in adult bronchiectasis patients. BMC Microbiol. 14, 130 (2014).","journal-title":"BMC Microbiol."},{"key":"42862_CR5","first-page":"25","volume":"6","author":"CD Sibley","year":"2011","unstructured":"Sibley, C. D. et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One 6, 25\u201327 (2011).","journal-title":"PLoS One"},{"key":"42862_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","volume":"68","author":"GB Rogers","year":"2013","unstructured":"Rogers, G. B. et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 68, 731\u20137 (2013).","journal-title":"Thorax"},{"key":"42862_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0035-1546752","volume":"36","author":"H Green","year":"2015","unstructured":"Green, H. & Jones, A. M. The Microbiome and Emerging Pathogens in Cystic Fibrosis and Non\u2013Cystic Fibrosis Bronchiectasis. Semin. Respir. Crit. Care Med. 36, 225\u2013235 (2015).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"42862_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ismej.2014.124","volume":"9","author":"GB Rogers","year":"2015","unstructured":"Rogers, G. B., van der Gast, C. J. & Serisier, D. J. Predominant pathogen competition and core microbiota divergence in chronic airway infection. ISME J. 9, 217\u2013225 (2015).","journal-title":"ISME J."},{"key":"42862_CR9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/ismej.2010.175","volume":"5","author":"CJ van der Gast","year":"2011","unstructured":"van der Gast, C. J. et al. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J. 5, 780\u2013791 (2011).","journal-title":"ISME J."},{"key":"42862_CR10","doi-asserted-by":"publisher","first-page":"e11044","DOI":"10.1371\/journal.pone.0011044","volume":"5","author":"MJ Cox","year":"2010","unstructured":"Cox, M. J. et al. Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients. PLoS One 5, e11044 (2010).","journal-title":"PLoS One"},{"key":"42862_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep10241","volume":"5","author":"B Coburn","year":"2015","unstructured":"Coburn, B. et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci. Rep. 5, 10241 (2015).","journal-title":"Sci. Rep."},{"key":"42862_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0074-9","volume":"3","author":"LA Carmody","year":"2015","unstructured":"Carmody, L. A. et al. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation. Microbiome 3, 12 (2015).","journal-title":"Microbiome"},{"key":"42862_CR13","doi-asserted-by":"crossref","unstructured":"Acosta, N. et al. The Evolving Cystic Fibrosis Microbiome: A Comparitive Cohort Study Spanning Sixteen Years. Ann. Am. Thorac. Soc. 14\u00a0 1288\u20131297\u00a0(2017).","DOI":"10.1513\/AnnalsATS.201609-668OC"},{"key":"42862_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/thoraxjnl-2018-211510","volume":"73","author":"N Acosta","year":"2018","unstructured":"Acosta, N. et al. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis. Thorax 73, 1016\u20131025 (2018).","journal-title":"Thorax"},{"issue":"2","key":"42862_CR15","doi-asserted-by":"publisher","first-page":"e0170622","DOI":"10.1371\/journal.pone.0170622","volume":"12","author":"Michael J. Cox","year":"2017","unstructured":"Cox, M. J. et al. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-CF bronchiectasis patients. PLoS One 12, e0170622 (2017).","journal-title":"PLOS ONE"},{"key":"42862_CR16","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.1073\/pnas.1120577109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. USA 109, 5809\u201314 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42862_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","volume":"11","author":"GB Rogers","year":"2014","unstructured":"Rogers, G. B. et al. A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis. Ann. Am. Thorac. Soc. 11, 496\u2013503 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"42862_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0124348","volume":"10","author":"P Paganin","year":"2015","unstructured":"Paganin, P. et al. Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function. PLoS One 10, 1\u201319 (2015).","journal-title":"PLoS One"},{"key":"42862_CR19","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","volume":"187","author":"MM Tunney","year":"2013","unstructured":"Tunney, M. M. et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am. J. Respir. Crit. Care Med. 187, 1118\u20131126 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"42862_CR20","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","volume":"2","author":"GB Rogers","year":"2014","unstructured":"Rogers, G. B., Bruce, K. D., Martin, M. L., Burr, L. D. & Serisier, D. J. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet. Respir. Med. 2, 988\u2013996 (2014).","journal-title":"Lancet. Respir. Med."},{"key":"42862_CR21","doi-asserted-by":"publisher","first-page":"e0172811","DOI":"10.1371\/journal.pone.0172811","volume":"12","author":"FJ Whelan","year":"2017","unstructured":"Whelan, F. J. et al. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis. PLoS One 12, e0172811 (2017).","journal-title":"PLoS One"},{"key":"42862_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","volume":"10","author":"LA Carmody","year":"2013","unstructured":"Carmody, L. A. et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann. Am. Thorac. Soc. 10, 179\u2013187 (2013).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"42862_CR23","doi-asserted-by":"publisher","first-page":"e0142097","DOI":"10.1371\/journal.pone.0142097","volume":"10","author":"D Collie","year":"2015","unstructured":"Collie, D. et al. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium. PLoS One 10, e0142097 (2015).","journal-title":"PLoS One"},{"key":"42862_CR24","doi-asserted-by":"publisher","first-page":"00081","DOI":"10.1183\/23120541.00081-2015","volume":"2","author":"JD Chalmers","year":"2016","unstructured":"Chalmers, J. D. et al. The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res. 2, 00081\u20132015 (2016).","journal-title":"ERJ Open Res."},{"key":"42862_CR25","unstructured":"Fardon, T. et al. Identifying Modifiable Risk Factors for Rapid Lung Function Decline in Bronchiectasis. In American journal of respiratory and critical care medicine A2878 (2016)."},{"key":"42862_CR26","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","volume":"132","author":"MA Marti\u0301nez-Garci\u0301a","year":"2007","unstructured":"Marti\u0301nez-Garci\u0301a, M. A. Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis. Chest 132, 1565 (2007).","journal-title":"Chest"},{"key":"42862_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1183\/09031936.00203013","volume":"44","author":"DJ Smith","year":"2014","unstructured":"Smith, D. J. et al. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. Eur. Respir. J. 44, 922\u2013930 (2014).","journal-title":"Eur. Respir. J."},{"key":"42862_CR28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/thoraxjnl-2011-200932","volume":"67","author":"FA Stressmann","year":"2012","unstructured":"Stressmann, F. A. et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 67, 867\u2013873 (2012).","journal-title":"Thorax"},{"key":"42862_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"S Nielsen","year":"2016","unstructured":"Nielsen, S. et al. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"42862_CR30","doi-asserted-by":"publisher","first-page":"IAI.01275-15","DOI":"10.1128\/IAI.01275-15","volume":"84","author":"N Thevaranjan","year":"2016","unstructured":"Thevaranjan, N. et al. Streptococcus pneumoniae colonization disrupts the microbial community within the upper respiratory tract of aging mice. Infect. Immun. 84, IAI.01275-15 (2016).","journal-title":"Infect. Immun."},{"key":"42862_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1513\/AnnalsATS.201310-351OC","volume":"11","author":"FJ Whelan","year":"2014","unstructured":"Whelan, F. J. et al. The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann. Am. Thorac. Soc. 11, 513\u2013521 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"42862_CR32","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1128\/AEM.02772-10","volume":"77","author":"AK Bartram","year":"2011","unstructured":"Bartram, A. K., Lynch, M. D. J., Stearns, J. C., Moreno-Hagelsieb, G. & Neufeld, J. D. Generation of Multimillion-Sequence 16S rRNA Gene Libraries from Complex Microbial Communities by Assembling Paired-End Illumina Reads. Appl. Environ. Microbiol. 77, 3846\u20133852 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"42862_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0314-2","volume":"5","author":"FJ Whelan","year":"2017","unstructured":"Whelan, F. J. & Surette, M. G. A comprehensive evaluation of the sl1p pipeline for 16S rRNA gene sequencing analysis. Microbiome 5, 100 (2017).","journal-title":"Microbiome"},{"key":"42862_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10\u201312 (2011).","journal-title":"EMBnet.journal"},{"key":"42862_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-31","volume":"13","author":"AP Masella","year":"2012","unstructured":"Masella, A. P., Bartram, A. K., Truszkowski, J. M., Brown, D. G. & Neufeld, J. D. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 13, 31 (2012).","journal-title":"BMC Bioinformatics"},{"key":"42862_CR36","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069\u20135072 (2006).","journal-title":"Appl. Environ. Microbiol."},{"key":"42862_CR37","first-page":"153","volume":"2010","author":"Y Ye","year":"2011","unstructured":"Ye, Y. Identification and Quantification of Abundant Species from Pyrosequences of 16S rRNA by Consensus Alignment. Proceedings. (IEEE. Int. Conf. Bioinformatics Biomed). 2010, 153\u2013157 (2011).","journal-title":"Proceedings. (IEEE. Int. Conf. Bioinformatics Biomed)."},{"key":"42862_CR38","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261\u20137 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"42862_CR39","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1111\/1755-0998.12700","volume":"17","author":"L Auer","year":"2017","unstructured":"Auer, L., Mariadassou, M., O\u2019Donohue, M., Klopp, C. & Hernandez-Raquet, G. Analysis of large 16S rRNA Illumina data sets: Impact of singleton read filtering on microbial community description. Mol. Ecol. Resour. 17, e122\u2013e132 (2017).","journal-title":"Mol. Ecol. Resour."},{"issue":"6","key":"42862_CR40","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/nar\/gku1341","volume":"43","author":"Melanie Schirmer","year":"2015","unstructured":"Schirmer, M. et al. Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform. Nucleic Acids Res. 43, e37 (2015).","journal-title":"Nucleic Acids Research"},{"key":"42862_CR41","doi-asserted-by":"crossref","unstructured":"McMurdie, P. J. & Holmes, S. Phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLoS One 8, e61217\u00a0(2013).","DOI":"10.1371\/journal.pone.0061217"},{"key":"42862_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/ismej.2012.145","volume":"7","author":"GB Rogers","year":"2013","unstructured":"Rogers, G. B. et al. Reducing bias in bacterial community analysis of lower respiratory infections. ISME J. 7, 697\u2013706 (2013).","journal-title":"ISME J."},{"key":"42862_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1462-2920.2011.02550.x","volume":"14","author":"TM Gihring","year":"2012","unstructured":"Gihring, T. M., Green, S. J. & Schadt, C. W. Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. Environ. Microbiol. 14, 285\u2013290 (2012).","journal-title":"Environ. Microbiol."},{"key":"42862_CR44","doi-asserted-by":"publisher","first-page":"e1003531","DOI":"10.1371\/journal.pcbi.1003531","volume":"10","author":"PJ McMurdie","year":"2014","unstructured":"McMurdie, P. J. & Holmes, S. Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible. PLoS Comput. Biol. 10, e1003531 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"42862_CR45","first-page":"32","volume":"26","author":"M Anderson","year":"2001","unstructured":"Anderson, M. A new method for non parametric multivariate analysis of variance. Austral Ecol. 26, 32\u201346 (2001).","journal-title":"Austral Ecol."},{"key":"42862_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"42862_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2009","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis. (Springer-Verlag, New York, 2009)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42862-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:13:35Z","timestamp":1671250415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42862-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42862"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42862-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"11 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.E.W., R.L., A.A.H., N.A., C.H.M., R.S. and C.D. declare no competing interests.\u00a0M.D.P., H.R.R. and M.G.S. have received research support from Gilead Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6871"}}